GP-Pharm   Report issue

For profit Phase 3
Founded: Barcelona Spain (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2005
NCT00128531
First Marketed Drug
2018
leuprolide (lupron)
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

GP-PHARM SA